GSK097 is a potent, BD2-selective BET inhibitor with >2000-fold selectivity for BRD4 BD2 over BD1 and solubility >1 mg/mL in FaSSIF. It is a valuable chemical probe for studying BD2-specific biology in oncology and inflammation research, enabling both in vitro mechanistic studies and in vivo model validation.
Molekulargewicht:
339.395
CAS Nummer:
[2159137-02-5]
Formel:
C19H21N3O3
Target-Kategorie:
Epigenetic Reader Domain,Others
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten